Advertisement
In contrast to findings in black adolescents and adults

Step-Up Strategy May Differ in Black Children With Asthma

0
Poorly controlled asthma in black children may respond to increased dose of inhaled glucocorticoid
Most protected health information breaches compromise sensitive demographic and/or financial information

Protected Health Info Breaches Compromise Sensitive Data

0
Most hospital data breaches include demographic or financial information that could be used for identity theft
Asthma is a common reason for physician visits

CDC: Asthma Visit Rates Decreased From 2001 to 2016

0
Asthma education and asthma action plans provided in 21.4 and 9.9 percent of asthma visits, respectively
Marijuana use is common among adults with medical conditions

Marijuana Use Common Among Adults With Medical Conditions

0
Prevalence of marijuana use decreases with increasing age
Medical education does not equip students to provide high-quality

Medical Students Not Ready to Provide Nutritional Care

0
Findings consistent regardless of country of training, year of medical education
Allergy immunotherapy is associated with a decreased risk for asthma progression

Allergy Immunotherapy May Decrease Asthma Progression

0
Findings strongest for youngest patients with incident asthma treated in routine care
Financial integration between physicians and hospitals raises patient spending but does not impact care quality

Spending Up With Treatment in Hospital-Owned Practices

0
Difference in spending seems to be due to greater service utilization; no difference seen in care quality
The eventual elimination of chemical testing on mammals was announced Tuesday by the U.S. Environmental Protection Agency.

EPA to Phase Out Chemical Testing on Mammals

0
Agency plans 30 percent reduction in number of studies that require use of mammals by 2025
The percentage of Americans living in poverty declined in 2018

Poverty Rate Drops, but Fewer Americans Have Health Insurance

0
8.5 percent of population lacked health insurance for all of 2018, up from 7.9 percent in 2017
Extended peanut sublingual immunotherapy demonstrates clinically significant desensitization in children with peanut allergies

Sublingual Immunotherapy Safely Desensitizes Pediatric Peanut Allergies

0
Extended therapy for up to five years safe, shows evidence of immune modulation